Stem Cell Therapy Market Overview and Introduction

The global stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030. The global stem cell therapy market is segmented by type, therapeutic application, and region.

Stem cells are cells which have ability to differentiate into various types of other cells and ultimately form organs or tissues. Stem cells are mainly of two type embryonic stem cells and adult stem cells. Over the years many researchers have carried out studies to evaluate the true potential of stem cells leading to various applications in the field of organ regeneration, genetic diseases treatment, oncology and cell therapy in damaged cells.

The global stem cell therapy market is driven by technological advancements in the stem cell therapy arena, increasing patient awareness and health care expenditure, rising number of patients genetic disorders, and need for regenerative medicine are major factors driving the market. However, high cost related to stem cell therapy research and ethical issue related to stem cells is likely to restrain the market to certain extent.

Stem Cell Therapy Market by Type

On the basis of type, the stem cell therapy market is segmented into allogeneic stem cell therapy and autologous stem cell therapy.

Stem Cell Therapy Market by Therapeutic

Allogeneic stem cell therapy segments accounted for the largest share of the market. Growth of this segment can be attributed to increasing focus on commercializing allogeneic stem cell products by companies to cater to a broad range of therapeutic applications.

Stem Cell Therapy Market by Application

Based on application, the market is segmented into musculoskeletal disorders, cardiovascular diseases, gastrointestinal diseases, wounds and injuries, surgeries and other applications.

Stem Cell Therapy Market by Regions

The global stem cell therapy market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of stem cell therapy market, followed by Europe and Asia Pacific. North America and other regions like Asia Pacific is anticipated to dominate the global stem cell therapy market in the forecast period owing to factors such as growing need of stem cell therapy products, advancement in technology, highly developed healthcare system and availability of government and private funding for research on stem cell.

Stem Cell Therapy Market Prominent Players

The prominent players in the global Stem Cell Therapy market are Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Ltd, Holostem Terapie Avanzate S.r.l, .JCR Pharmaceuticals Co., NuVasive, Inc., RTI Surgical, Inc , and AlloSource